Immunisation against meningococcal disease is the best protection against meningococcal disease.
Who should get immunised?
Meningococcal C vaccine is part of the National Immunisation Program and is free for children aged 12 months. Meningococcal C disease is now very well controlled with only a handful of cases per year.
Quadrivalent meningococcal vaccine protects against strains A, C, W and Y
In most states/territories, the vaccine is free for adolescents between 15-19 years of age. In states where it is not funded, the vaccine is available as a private prescription for adolescents.
Vaccine is also available as a private prescription for:
- Some travel destinations, occupations and medical conditions
- Anyone over 2 months* wanting to protect themselves or their family from these strains of meningococcal disease
* Menveo is the only brand of 4vMenCV that should be used in infants <12 months of age
Meningococcal B vaccine is available on private prescription for:
- Infants, young children, adolescents, young adults living close together, some medical conditions and occupations
- Anyone over 6 weeks* wanting to protect themselves or their family from this strain of meningococcal
* MenBV is registered for use from 2 months of age. However, the 1st dose can be given as early as 6 weeks of age to align with the schedule for other routine infant vaccines.
 Meningococcal vaccines for Australians/NCIRS Fact sheet: March 2017
 The Australian Immunisation Handbook 10th ed part 4 (page last updated 1st August 2017). Canberra: Australian Government Department of Health; 2015